Rapid high yield production of different glycoforms of ebola virus monoclonal antibody

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Castilho, Alexandra ^a   Bohorova, Natasha ^b   Grass, Josephine ^a   Bohorov, Ognian ^b   Zeitlin, Larry ^b   Whaley, Kevin ^b   Altmann, Friedrich ^a   Steinkellner, Herta ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b Mapp Biopharmaceutical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FC RECEPTOR; GLYCAN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; N ACETYLGLUCOSAMINE; PLANTIBODY;

ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; EBOLA VIRUS; ENZYME LOCALIZATION; FUCOSYLATION; GENE EXPRESSION SYSTEM; GENE TARGETING; GLYCOSYLATION; GOLGI COMPLEX; NICOTIANA BENTHAMIANA; PLANT VIRUS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; WILD TYPE; BIOSYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; IMMUNOLOGY; LIQUID CHROMATOGRAPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TOBACCO;

EBOLA VIRUS; MAMMALIA; NICOTIANA BENTHAMIANA;

ANTIBODIES, MONOCLONAL; CHROMATOGRAPHY, LIQUID; EBOLAVIRUS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOSYLATION; PLANTIBODIES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TOBACCO;

EID: 80055046005     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026040     Document Type: Article

References (31)

1. Rich JR, Withers SG, (2009) Emerging methods for the production of homogeneous human glycoproteins. Nat Chem Biol 5: 206-15.
2. Jefferis R, (2009) Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 8: 226-34.
3. Rudd PM, Joao HC, Coghill E, Fiten P, Saunders MR, et al. (1994) Glycoforms modify the dynamic stability and functional activity of an enzyme. Biochemistry 33: 17-22.
4. Marillonnet S, Thoeringer C, Kandzia R, Klimyuk V, Gleba Y, (2005) Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat Biotechnol 23: 718-23.
5. Sainsbury F, Lomonossoff GP, (2008) Extremely high-level and rapid transient protein production in plants without the use of viral replication. Plant Physiol 148: 1212-8.
6. Bendandi M, Marillonnet S, Kandzia R, Thieme F, Nickstadt A, et al. (2010) Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma Ann. Oncol 21: 2420-7.
7. Ahlquist P, Schwartz M, Chen J, Kushner D, Hao L, et al. (2005) Viral and host determinants of RNA virus vector replication and expression. Vaccine 23: 1784-7.
8. Kushner DB, Lindenbach BD, Grdzelishvili VZ, Noueiry AO, Paul SM, et al. (2003) Systematic, genome-wide identification of host genes affecting replication of a positive-strand RNA virus. Proc Natl Acad Sci U S A 100: 15764-9.
9. Carette JE, van Lent J, MacFarlane SA, Wellink J, van Kammen A, (2002) Cowpea mosaic virus 32- and 60-kilodalton replication proteins target and change the morphology of endoplasmic reticulum membranes. J Virol 76: 6293-301.
10. Cox KM, Sterling JD, Regan JT, Gasdaska JR, Frantz KK, et al. (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 24: 1591-7.
11. Schuster M, Jost W, Mudde GC, Wiederkum S, Schwager C, et al. (2007) In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system. Biotechnol J2: 700-8.
12. Schähs M, Strasser R, Stadlmann J, Kunert R, Rademacher T, et al. (2007) Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol J 5: 657-63.
13. Strasser R, Stadlmann J, Schähs M, Stiegler G, Quendler H, et al. (2008) Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 6: 392-402.
14. Castilho A, Strasser R, Stadlmann J, Grass J, Jez J, et al. (2010) In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 285: 15923-30.
15. Castilho A, Gattinger P, Grass J, Jez J, Pabst M, et al. (2011) N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 21: 813-23.
16. Forthal DN, Gach JS, Landucci G, Jez J, Strasser R, et al. (2010) Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J Immunol 185: 6876-82.
17. Strasser R, Castilho A, Stadlmann J, Kunert R, Quendler H, et al. (2009) Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J Biol Chem 284: 20479-85.
18. Wilson JA, Hevey M, Bakken R, Guest S, Bray M, et al. (2000) Epitopes involved in antibody-mediated protection from Ebola virus. Science 287: 1664-6.
19. Zeitlin L, Pettitt J, Scully C, Bohorova N, Kim D, et al. (accepted) Design and testing of an Ebola virus post-exposure immunoprotectant: enhanced potency of a fucose free monoclonal antibody.
20. Stadlmann J, Pabst M, Kolarich D, Kunert R, Altmann F, (2008) Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 8: 2858-71.
21. Ferrara C, Brünker P, Suter T, Moser S, Püntener U, et al. (2006) Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II. Biotechnol Bioeng 93: 851-61.
22. Rouwendal GJ, Wuhrer M, Florack DE, Koeleman CA, Deelder AM, et al. (2007) Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. Glycobiology 17: 334-44.
23. Sainsbury F, Sack M, Stadlmann J, Quendler H, Fischer R, et al. (2010) Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody. PLoS One 5 (11): e13976.
24. De Muynck B, Navarre C, Boutry M, (2010) Production of antibodies in plants: status after twenty years. Plant Biotechnol J8: 529-63.
25. Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, et al. (2001) Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science 293: 1155-1159.
26. Hamilton SR, Gerngross TU, (2007) Glycosylation engineering in yeast: the advent of fully humanized yeast. Curr Opin Biotechnol 18: 387-92.
27. Bakker H, Rouwendal GJ, Karnoup AS, Florack DE, Stoopen GM, et al. (2006) An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc Natl Acad Sci U S A 103: 7577-82.
28. Umaña P, Jean-Mairet J, Moudry R, Amstutz H, Bailey JE, (1999) Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol 17: 176-80.
29. Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, et al. (2010) Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma J Clin Oncol 28: 1591-1598.
30. Junttila TT, Parsons K, Olsson C, Lu Y, Xin Y, et al. (2010) Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer. Cancer Res 2010 70: 4481-9.
31. Tretter V, Altmann F, März L, (1991) Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase F cannot release glycans with fucose attached alpha 1→3 to the asparagine-linked N-acetylglucosamine residue. Eur J Biochem 199: 647-52.